Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review
Frontiers in Bioengineering and Biotechnology · 07.11.2023 · 11
DOI: 10.3389/fbioe.2023.1299033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 07.11.2023. Verfasst von Leqing Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Shenzhen Hospital, Southern Medical University, Shenzhen, China. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer has become the primary cause of cancer-related deaths because of its high recurrence rate, ability to metastasise easily, and propensity to develop drug resistance. The wide-ranging heterogeneity of lung cancer subtypes increases the complexity of developing effective therapeutic interventions. Therefore, personalised diagnostic and treatment strategies are required to guide clinical practice. The advent of innovative three-dimensional (3D) culture systems such as organoid and organ-on-a-chip models provides opportunities to address these challenges and revolutionise lung cancer research and drug evaluation. In this review, we introduce the advancements in lung-related 3D culture systems, with a particular focus on lung organoids and lung-on-a-chip, and their latest contributions to lung cancer research and drug evaluation. These developments include various aspects, from authentic simulations and mechanistic enquiries into lung cancer to assessing chemotherapeutic agents and targeted therapeutic interventions. The new 3D culture system can mimic the pathological and physiological microenvironment of the lung, enabling it to supplement or replace existing two-dimensional culture models and animal experimental models and realize the potential for personalised lung cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
- Shenzhen Clinical Medical College, Southern Medical University, Shenzhen, China.
- Materials Genome Institute, Shanghai University, Shanghai, China.
Zitieren
APA
Zhu, L., Zhang, J., Guo, Q., Kuang, J., Li, D., Wu, M., Mo, Y., Zhang, T., Gao, X., & Tan, J. (2023). Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review. Frontiers in Bioengineering and Biotechnology, 11. https://doi.org/10.3389/fbioe.2023.1299033
Vancouver
Zhu L, Zhang J, Guo Q, Kuang J, Li D, Wu M, et al. Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review. Frontiers in Bioengineering and Biotechnology. 2023;11. doi:10.3389/fbioe.2023.1299033
BibTeX
@article{Zhu2023,
author = {Zhu, Leqing and Zhang, Jianhua and Guo, Quanwei and Kuang, Jun and Li, Dongfang and Wu, Mengxi and Mo, Yijun and Zhang, Tao and Gao, Xinghua and Tan, Jianfeng},
title = {Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2023},
volume = {11},
doi = {10.3389/fbioe.2023.1299033}
}
EUVIMED